Bio-Techne (TECH) Shares Outstanding (Weighted Average) (2009 - 2026)
Bio-Techne's quarterly Shares Outstanding (Weighted Average) came in at $155.9 million in Q1 2026, down 1.41% year-on-year from $158.1 million in Q1 2025, and little changed quarter-over-quarter from $155.8 million in Q4 2025.
Bio-Techne has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $155.9 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 1.41% year-over-year to $155.9 million; the trailing twelve-month figure through Mar 2026 stood at $155.9 million (down 1.41% YoY), and the FY2025 full-year result was $157.5 million, changed 0.12% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $155.9 million, roughly flat from $155.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $158.5 million in Q3 2024, with the low at $155.5 million in Q3 2025.
- Average Shares Outstanding (Weighted Average) over 5 years is $157.2 million, with a median of $157.2 million recorded in 2023.
- Year-over-year, Shares Outstanding (Weighted Average) jumped 305.98% in 2022 and retreated 1.93% in 2025.
- Tracing TECH's Shares Outstanding (Weighted Average) over 5 years: stood at $156.9 million in 2022, then climbed by 0.41% to $157.5 million in 2023, then gained by 0.6% to $158.5 million in 2024, then decreased by 1.67% to $155.8 million in 2025, then advanced by 0.03% to $155.9 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $155.9 million (Q1 2026), $155.8 million (Q4 2025), and $155.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 155.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155.89 Mn |
| Dec 31, 2025 | 155.84 Mn |
| Sep 30, 2025 | 155.46 Mn |
| Jun 30, 2025 | 157.52 Mn |
| Mar 31, 2025 | 158.12 Mn |
| Dec 31, 2024 | 158.48 Mn |
| Sep 30, 2024 | 158.53 Mn |
| Jun 30, 2024 | 157.71 Mn |
| Mar 31, 2024 | 157.31 Mn |
| Dec 31, 2023 | 157.53 Mn |
| Sep 30, 2023 | 158.13 Mn |
| Jun 30, 2023 | 157.18 Mn |
| Mar 31, 2023 | 157.07 Mn |
| Dec 31, 2022 | 156.89 Mn |
| Sep 30, 2022 | 156.93 Mn |
| Jun 30, 2022 | 156.87 Mn |
| Mar 31, 2022 | 157.09 Mn |
| Dec 31, 2021 | 39.31 Mn |
| Sep 30, 2021 | 39.09 Mn |
| Jun 30, 2021 | 154.99 Mn |
| Mar 31, 2021 | 38.69 Mn |
| Dec 31, 2020 | 38.69 Mn |
| Sep 30, 2020 | 38.54 Mn |
| Jun 30, 2020 | 38.20 Mn |
| Mar 31, 2020 | 38.30 Mn |
| Dec 31, 2019 | 38.17 Mn |
| Sep 30, 2019 | 38.03 Mn |
| Jun 30, 2019 | 37.78 Mn |
| Mar 31, 2019 | 37.77 Mn |
| Dec 31, 2018 | 37.77 Mn |
| Sep 30, 2018 | 37.70 Mn |
| Jun 30, 2018 | 37.48 Mn |
| Mar 31, 2018 | 37.50 Mn |
| Dec 31, 2017 | 37.45 Mn |
| Sep 30, 2017 | 37.38 Mn |
| Jun 30, 2017 | 37.31 Mn |
| Mar 31, 2017 | 37.32 Mn |
| Dec 31, 2016 | 37.31 Mn |
| Sep 30, 2016 | 37.28 Mn |
| Jun 30, 2016 | 37.19 Mn |
| Mar 31, 2016 | 37.20 Mn |
| Dec 31, 2015 | 37.19 Mn |
| Sep 30, 2015 | 37.17 Mn |
| Jun 30, 2015 | 37.10 Mn |
| Mar 31, 2015 | 37.14 Mn |
| Dec 31, 2014 | 37.09 Mn |
| Sep 30, 2014 | 37.01 Mn |
| Jun 30, 2014 | 36.89 Mn |
| Mar 31, 2014 | 36.91 Mn |
| Dec 31, 2013 | 36.86 Mn |
| Sep 30, 2013 | 36.84 Mn |
| Jun 30, 2013 | 36.84 Mn |
| Mar 31, 2013 | 36.84 Mn |
| Dec 31, 2012 | 36.83 Mn |
| Sep 30, 2012 | 36.83 Mn |
| Jun 30, 2012 | 36.94 Mn |
| Mar 31, 2012 | 36.98 Mn |
| Dec 31, 2011 | 36.97 Mn |
| Sep 30, 2011 | 37.10 Mn |
| Jun 30, 2011 | 37.10 Mn |
| Mar 31, 2011 | 37.12 Mn |
| Dec 31, 2010 | 37.09 Mn |
| Sep 30, 2010 | 37.04 Mn |
| Jun 30, 2010 | 37.26 Mn |
| Mar 31, 2010 | 37.26 Mn |
| Dec 31, 2009 | 37.25 Mn |
| Sep 30, 2009 | 37.25 Mn |
| Jun 30, 2009 | 37.80 Mn |